Page 109 - Read Online
P. 109
Page 20 of 20 Zhang et al. Cancer Drug Resist 2024;7:34 https://dx.doi.org/10.20517/cdr.2024.59
potential. J Hematol Oncol 2023;16:67. DOI PubMed PMC
189. Guo X, Gao C, Yang DH, Li S. Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance. Drug Resist Updat
2023;67:100937. DOI PubMed
190. Li K, Crews CM. PROTACs: past, present and future. Chem Soc Rev 2022;51:5214-36. DOI PubMed PMC
191. Marei H, Tsai WK, Kee YS, et al. Antibody targeting of E3 ubiquitin ligases for receptor degradation. Nature 2022;610:182-9. DOI
PubMed PMC
192. Xiong Y, Zhong Y, Yim H, et al. Bridged proteolysis targeting chimera (PROTAC) enables degradation of undruggable targets. J Am
Chem Soc 2022;144:22622-32. DOI PubMed PMC
193. Ghidini A, Cléry A, Halloy F, Allain FHT, Hall J. RNA-PROTACs: degraders of RNA-binding proteins. Angew Chem Int Ed Engl
2021;60:3163-9. DOI PubMed PMC
194. Li X, Pu W, Zheng Q, Ai M, Chen S, Peng Y. Proteolysis-targeting chimeras (PROTACs) in cancer therapy. Mol Cancer 2022;21:99.
DOI PubMed PMC
195. Wu Y, Chang X, Yang G, et al. A physiologically responsive nanocomposite hydrogel for treatment of head and neck squamous cell
carcinoma via proteolysis-targeting chimeras enhanced immunotherapy. Adv Mater 2023;35:e2210787. DOI PubMed
196. Jin J, Wu Y, Zhao Z, et al. Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial
cancer. JCI Insight 2022;7:e160606. DOI PubMed PMC
197. Kuismi CC, Nabet B. Lighting the way to tumor destruction. Trends Pharmacol Sci 2023;44:750-2. DOI PubMed PMC
198. Yang F, Luo Q, Wang Y, et al. Targeted biomolecule regulation platform: a split-and-mix PROTAC approach. J Am Chem Soc
2023;145:7879-87. DOI PubMed
199. Collins R. What makes UK Biobank special? Lancet 2012;379:1173-4. DOI PubMed
200. Zhang C, Xu J, Tang R, et al. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment. J
Hematol Oncol 2023;16:114. DOI PubMed PMC
201. Tayebi Arasteh S, Han T, Lotfinia M, et al. Large language models streamline automated machine learning for clinical studies. Nat
Commun 2024;15:1603. DOI PubMed PMC
